US reclassifies cannabis, raising possibility of marijuana legalisation - BBC
Quick Insights
The Bottom Line
The U.S. government reclassified cannabis from Schedule I to Schedule III, easing federal restrictions.
How This Affects You
This reclassification could lead to broader state-level medical marijuana programs and impact federal banking and tax policies for cannabis businesses.
AI Summary
The United States government has reclassified cannabis, moving it from Schedule I to Schedule III under the Controlled Substances Act. This administrative action acknowledges cannabis's accepted medical uses and lower potential for abuse compared to drugs like heroin. The reclassification significantly reduces federal restrictions on cannabis, potentially easing research and medical access. This change, initiated by the Department of Health and Human Services and approved by the Drug Enforcement Administration, could pave the way for broader state-level medical marijuana programs and impact federal banking and tax policies for cannabis businesses. While not outright federal legalization, it marks a historic shift in federal drug policy regarding marijuana.
What's Being Done
The Department of Health and Human Services initiated the change, and the Drug Enforcement Administration approved it.
Source Coverage Map
13 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
5 sourcesMultiple outlets have reported on this story. Compare perspectives from different sources.
This article is part of a story we're tracking:
Trump Administration's Reclassification of Marijuana
The Trump administration has reclassified state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act, a move that significantly eases restrictions and could impact future legalization efforts.
Trump Administration Reclassifies Marijuana
The Trump administration has reclassified state-licensed medical marijuana as a 'less-dangerous drug,' moving it from Schedule I to Schedule III under the Controlled Substances Act. This significant policy shift is expected to ease research barriers and impact the growing cannabis industry.
Civil Rights & Justice
Following developments in civil rights, criminal justice reform, voting rights, Supreme Court decisions, policing accountability, and the ongoing struggle for equality and justice across American institutions.
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
PoliticsUS set to move to reclassify marijuana as early as Wednesday, Axios reports - Reuters
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQRXVmb2RINXd2NTJ2S0FPYl9FUi1KbkpHekVnVnA3MWdwQ3RGSkJkQjN6Z2tmQzM4bEVoTkthZzJWUG1KLXRsMlhhSGtqSHRLNEJFcjRKelBpSUp6bm55TDlwZTFkOUpybU5RdkJKRzhWX2dwU1pLTVRoc0MxV2I1cldyRkQ0X0tOVlVBVDI1LUU4NTFEUjFKR3hJdF90MERBNElWNQ?oc=5" target="_blank">US set to reclassify marijuana as early as Wednesday, Axios reports</a> <font color="#6f6f6f">Reuters</font>
PoliticsScoop: Trump set to reclassify marijuana soon
<p>The <a href="https://www.axios.com/politics-policy/donald-trump" target="_blank">Trump</a> administration is expected to move to <a href="https://www.axios.com/2025/12/18/trump-reclassify-marijuana-weed-schedule-drugs" target="_blank">reclassify</a> marijuana as soon as Wednesday, per an administration official familiar with the matter.</p><p><strong>Why it matters: </strong>The move would make it easier to study medicinal applications of marijuana and could shore up support from <a href="https://www.axios.com/2026/04/20/trump-woos-rogan-after-split" target="_blank">influencers</a> who support the research.</p><hr><ul><li>The move follows an executive order from the president last year to reclassify marijuana as a Schedule III drug, which is a years-long process. </li></ul><p><strong>How it works: </strong><a href="https://www.axios.com/2025/12/12/trump-marijuana-federal-restrictions-reclassify" target="_blank">Reclassifying</a> marijuana eases U.S. Drug Enforcement Administratio...
PoliticsDemocratic, Republican strategists on fundraising before midterm elections
New data is emerging on fundraising efforts ahead of the 2026 midterm elections. Political strategists Chuck Rocha and Carrie Lukas join CBS News with more.
PoliticsWhy a Democratic Senate, Once Unthinkable, Is a Real Possibility
Helped by a favorable national environment and strong candidate recruitment, Democrats are tied or ahead in four Republican-held seats, polls show.
PoliticsDemocrats dominate midterm fundraising, but Republicans have a huge cash advantage
The latest campaign finance reports show Democratic enthusiasm in key House and Senate races, but national Republican groups have far more in the bank to potentially spend down the road.
PoliticsMeet the new power players raising massive money for the midterms - Politico
Trump reclassifies state-licensed medical marijuana as less-dangerous drug
The order signed by Todd Blanche does not legalize marijuana for medical or recreational use under federal law. But it does change the way it's regulated.
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
One in three Americans forced to make financial sacrifices for health coverage
Trump-branded data center project CEO departs
6 crew still missing after overturned ship that disappeared after typhoon is found near Saipan - AP News
US Live Nation and Ticketmaster verdict triggers calls for Australian investigation into ticketing rules
